0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Distinct beta-arrestin coupling and intracellular trafficking of metabotropic glutamate receptor homo- and heterodimers

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The metabotropic glutamate receptors (mGluRs) are family C, dimeric G protein–coupled receptors (GPCRs), which play critical roles in synaptic transmission. Despite an increasing appreciation of the molecular diversity of this family, how distinct mGluR subtypes are regulated remains poorly understood. We reveal that different group II/III mGluR subtypes show markedly different beta-arrestin (β-arr) coupling and endocytic trafficking. While mGluR2 is resistant to internalization and mGluR3 shows transient β-arr coupling, which enables endocytosis and recycling, mGluR8 and β-arr form stable complexes, which leads to efficient lysosomal targeting and degradation. Using chimeras and mutagenesis, we pinpoint carboxyl-terminal domain regions that control β-arr coupling and trafficking, including the identification of an mGluR8 splice variant with impaired internalization. We then use a battery of high-resolution fluorescence assays to find that heterodimerization further expands the diversity of mGluR regulation. Together, this work provides insight into the relationship between GPCR/β-arr complex formation and trafficking while revealing diversity and intricacy in the regulation of mGluRs.

          Abstract

          Homo- and hetero-dimeric mGluR complexes show diverse modes of regulation by beta-arrestins.

          Related collections

          Most cited references95

          • Record: found
          • Abstract: found
          • Article: not found

          Metabotropic glutamate receptors: physiology, pharmacology, and disease.

          The metabotropic glutamate receptors (mGluRs) are family C G-protein-coupled receptors that participate in the modulation of synaptic transmission and neuronal excitability throughout the central nervous system. The mGluRs bind glutamate within a large extracellular domain and transmit signals through the receptor protein to intracellular signaling partners. A great deal of progress has been made in determining the mechanisms by which mGluRs are activated, proteins with which they interact, and orthosteric and allosteric ligands that can modulate receptor activity. The widespread expression of mGluRs makes these receptors particularly attractive drug targets, and recent studies continue to validate the therapeutic utility of mGluR ligands in neurological and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, anxiety, depression, and schizophrenia.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert

            Glutamate serves as both the mammalian brain’s primary excitatory neurotransmitter and as a key neuromodulator to control synapse and circuit function over a wide range of spatial and temporal scales. This functional diversity is decoded by two receptor families: ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs). The challenges posed by the complexity and physiological importance of each of these subtypes has limited our appreciation and understanding of how these receptors work in concert. In this review, by comparing both receptor families with a focus on their crosstalk, we argue for a more holistic understanding of neural glutamate signaling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Metabotropic glutamate receptors: from the workbench to the bedside.

              Metabotropic glutamate (mGlu) receptors were discovered in the mid 1980s and originally described as glutamate receptors coupled to polyphosphoinositide hydrolysis. Almost 6500 articles have been published since then, and subtype-selective mGlu receptor ligands are now under clinical development for the treatment of a variety of disorders such as Fragile-X syndrome, schizophrenia, Parkinson's disease and L-DOPA-induced dyskinesias, generalized anxiety disorder, chronic pain, and gastroesophageal reflux disorder. Prof. Erminio Costa was linked to the early times of the mGlu receptor history, when a few research groups challenged the general belief that glutamate could only activate ionotropic receptors and all metabolic responses to glutamate were secondary to calcium entry. This review moves from those nostalgic times to the most recent advances in the physiology and pharmacology of mGlu receptors, and highlights the role of individual mGlu receptor subtypes in the pathophysiology of human disorders. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'. Copyright © 2010 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: ValidationRole: Visualization
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: ResourcesRole: Validation
                Role: ConceptualizationRole: InvestigationRole: MethodologyRole: Validation
                Role: Formal analysisRole: InvestigationRole: MethodologyRole: ResourcesRole: ValidationRole: Visualization
                Role: Data curationRole: InvestigationRole: Resources
                Role: ConceptualizationRole: Writing - review & editing
                Role: ConceptualizationRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Journal
                Sci Adv
                Sci Adv
                sciadv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                08 December 2023
                06 December 2023
                : 9
                : 49
                : eadi8076
                Affiliations
                [ 1 ]Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.
                [ 2 ]Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125 Berlin, Germany.
                [ 3 ]Department of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
                Author notes
                [* ]Corresponding author. Email: jtl2003@ 123456med.cornell.edu
                [†]

                These author contributed equally to this work.

                Author information
                https://orcid.org/0000-0003-3887-8540
                https://orcid.org/0000-0002-2817-2475
                https://orcid.org/0000-0003-4882-6162
                https://orcid.org/0000-0002-6733-7607
                https://orcid.org/0000-0003-4965-9669
                https://orcid.org/0000-0003-0149-3778
                https://orcid.org/0000-0003-3084-6595
                https://orcid.org/0000-0002-8169-6323
                Article
                adi8076
                10.1126/sciadv.adi8076
                10699790
                38055809
                7dc7b23b-f117-48e5-bbf5-9e86b1def9f4
                Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                History
                : 18 May 2023
                : 03 November 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000057, National Institute of General Medical Sciences;
                Award ID: R35GM124731
                Funded by: FundRef http://dx.doi.org/10.13039/100000057, National Institute of General Medical Sciences;
                Award ID: F32GM148001
                Funded by: FundRef http://dx.doi.org/10.13039/100000065, National Institute of Neurological Disorders and Stroke;
                Award ID: R01NS129904
                Funded by: FundRef http://dx.doi.org/10.13039/100023581, National Science Foundation Graduate Research Fellowship Program;
                Funded by: The Rohr Family Research Scholar Award;
                Funded by: The Monique Weill-Caulier Award;
                Funded by: The Margarita Salas Fellowship from the Ministry of Universities of Spain;
                Categories
                Research Article
                Biomedicine and Life Sciences
                SciAdv r-articles
                Biophysics
                Cell Biology
                Cell Biology
                Custom metadata
                Fritzie Benzon

                Comments

                Comment on this article